Botulinum Toxin
Botulinum Toxin is a pharmaceutical drug with 41 clinical trials. Currently 8 active trials ongoing. Historical success rate of 90.0%.
Success Metrics
Based on 18 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
9
Mid Stage
16
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.8%
18 of 22 finished
18.2%
4 ended early
8
trials recruiting
41
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization
Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction
Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb
Clinical Trials (41)
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization
Individualised Cryoneurolysis to Treat Pain in the Context of Spasticity in the Upper and Lower Extremities
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
Cyclops Syndrome After Anterior Cruciate Ligament Reconstruction
Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb
Botulinum Toxin Therapy in Hidradenitis Suppurativa
Botulinum Toxin in Raynaud's Phenomenon
Low or High Botox Dilution for the Hemiplegic Gait?
Effect of Topical Botulinum Toxin Eyedrop on Palpebral Fissure
Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
Effect of Different Treatment Techniques on Masseter Muscle Thickness
Effectiveness of Botox, Dry Needling, Pharmacological Treatment, and Manual Therapy for Bruxism-Induced Myalgia
Strategy to Adapt Botulinum Toxin Doses in Dystonia
Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia
Treatment of Moderate to Severe Lateral Canthal Lines
Treatment of Moderate to Severe Glabellar Lines
Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee
Ultrasound and EMG Guided Botox Injection for the Treatment of Non-Relaxing Puborectalis Syndrome
Infiltrations of OnaBotulinum Toxin A in Resistant Depression: Comparison of Two Facial Injection Sites.
Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring (Allergan Botox Scar Study)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 41